These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 25936739)

  • 61. Sustained Reduction in Severe Hypoglycemia in Adults With Type 1 Diabetes Complicated by Impaired Awareness of Hypoglycemia: Two-Year Follow-up in the HypoCOMPaSS Randomized Clinical Trial.
    Little SA; Speight J; Leelarathna L; Walkinshaw E; Tan HK; Bowes A; Lubina-Solomon A; Chadwick TJ; Stocken DD; Brennand C; Marshall SM; Wood R; Kerr D; Flanagan D; Heller SR; Evans ML; Shaw JAM
    Diabetes Care; 2018 Aug; 41(8):1600-1607. PubMed ID: 29661916
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.
    van Beers CA; DeVries JH; Kleijer SJ; Smits MM; Geelhoed-Duijvestijn PH; Kramer MH; Diamant M; Snoek FJ; Serné EH
    Lancet Diabetes Endocrinol; 2016 Nov; 4(11):893-902. PubMed ID: 27641781
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Active assistance technology reduces glycosylated hemoglobin and weight in individuals with type 2 diabetes: results of a theory-based randomized trial.
    Orsama AL; Lähteenmäki J; Harno K; Kulju M; Wintergerst E; Schachner H; Stenger P; Leppänen J; Kaijanranta H; Salaspuro V; Fisher WA
    Diabetes Technol Ther; 2013 Aug; 15(8):662-9. PubMed ID: 23844570
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy and Safety of Glimepiride With or Without Linagliptin Treatment in Patients With HNF1A Diabetes (Maturity-Onset Diabetes of the Young Type 3): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial (GLIMLINA).
    Christensen AS; Hædersdal S; Støy J; Storgaard H; Kampmann U; Forman JL; Seghieri M; Holst JJ; Hansen T; Knop FK; Vilsbøll T
    Diabetes Care; 2020 Sep; 43(9):2025-2033. PubMed ID: 32661107
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide.
    Roach ; Koledova E; Metcalfe S; Hultman C; Milicevic Z;
    Clin Ther; 2001 Oct; 23(10):1732-44. PubMed ID: 11726007
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mobile App for Improved Self-Management of Type 2 Diabetes: Multicenter Pragmatic Randomized Controlled Trial.
    Agarwal P; Mukerji G; Desveaux L; Ivers NM; Bhattacharyya O; Hensel JM; Shaw J; Bouck Z; Jamieson T; Onabajo N; Cooper M; Marani H; Jeffs L; Bhatia RS
    JMIR Mhealth Uhealth; 2019 Jan; 7(1):e10321. PubMed ID: 30632972
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Empirically establishing blood glucose targets to achieve HbA1c goals.
    Wei N; Zheng H; Nathan DM
    Diabetes Care; 2014 Apr; 37(4):1048-51. PubMed ID: 24513588
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mobile Phone-Based Telemedicine Practice in Older Chinese Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial.
    Sun C; Sun L; Xi S; Zhang H; Wang H; Feng Y; Deng Y; Wang H; Xiao X; Wang G; Gao Y; Wang G
    JMIR Mhealth Uhealth; 2019 Jan; 7(1):e10664. PubMed ID: 30609983
    [TBL] [Abstract][Full Text] [Related]  

  • 69. ROSSO-in-praxi-international: long-term effects of self-monitoring of blood glucose on glucometabolic control in patients with type 2 diabetes mellitus not treated with insulin.
    Kempf K; Tankova T; Martin S
    Diabetes Technol Ther; 2013 Jan; 15(1):89-96. PubMed ID: 23194054
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prospective, randomized trial on intensive SMBG management added value in non-insulin-treated T2DM patients (PRISMA): a study to determine the effect of a structured SMBG intervention.
    Scavini M; Bosi E; Ceriello A; Giorgino F; Porta M; Tiengo A; Vespasiani G; Bottalico D; Marino R; Parkin C; Bonizzoni E; Cucinotta D
    Acta Diabetol; 2013 Oct; 50(5):663-72. PubMed ID: 22189755
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Feasibility and effectiveness of self-monitoring of blood glucose among insulin-dependent patients with type 2 diabetes: open randomized control trial in three rural districts in Rwanda.
    Ng'ang'a L; Ngoga G; Dusabeyezu S; Hedt-Gauthier BL; Harerimana E; Niyonsenga SP; Bavuma CM; Bukhman G; Adler AJ; Kateera F; Park PH
    BMC Endocr Disord; 2022 Oct; 22(1):244. PubMed ID: 36209209
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dapagliflozin as monotherapy in drug-naive Asian patients with type 2 diabetes mellitus: a randomized, blinded, prospective phase III study.
    Ji L; Ma J; Li H; Mansfield TA; T'joen CL; Iqbal N; Ptaszynska A; List JF
    Clin Ther; 2014 Jan; 36(1):84-100.e9. PubMed ID: 24378206
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Randomized Study to Evaluate the Impact of Telemedicine Care in Patients With Type 1 Diabetes With Multiple Doses of Insulin and Suboptimal HbA
    Ruiz de Adana MS; Alhambra-Expósito MR; Muñoz-Garach A; Gonzalez-Molero I; Colomo N; Torres-Barea I; Aguilar-Diosdado M; Carral F; Serrano M; Martínez-Brocca MA; Duran A; Palomares R;
    Diabetes Care; 2020 Feb; 43(2):337-342. PubMed ID: 31831473
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Web-Based TangPlan and WeChat Combination to Support Self-management for Patients With Type 2 Diabetes: Randomized Controlled Trial.
    Xia SF; Maitiniyazi G; Chen Y; Wu XY; Zhang Y; Zhang XY; Li ZY; Liu Y; Qiu YY; Wang J
    JMIR Mhealth Uhealth; 2022 Mar; 10(3):e30571. PubMed ID: 35353055
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial.
    Oskarsson P; Antuna R; Geelhoed-Duijvestijn P; Krӧger J; Weitgasser R; Bolinder J
    Diabetologia; 2018 Mar; 61(3):539-550. PubMed ID: 29273897
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Smart Care Based on Telemonitoring and Telemedicine for Type 2 Diabetes Care: Multi-Center Randomized Controlled Trial.
    Jeong JY; Jeon JH; Bae KH; Choi YK; Park KG; Kim JG; Won KC; Cha BS; Ahn CW; Kim DW; Lee CH; Lee IK
    Telemed J E Health; 2018 Aug; 24(8):604-613. PubMed ID: 29341843
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.
    Lind M; Polonsky W; Hirsch IB; Heise T; Bolinder J; Dahlqvist S; Schwarz E; Ólafsdóttir AF; Frid A; Wedel H; Ahlén E; Nyström T; Hellman J
    JAMA; 2017 Jan; 317(4):379-387. PubMed ID: 28118454
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis.
    Teo E; Hassan N; Tam W; Koh S
    Diabetologia; 2022 Apr; 65(4):604-619. PubMed ID: 35141761
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A Novel User Utility Score for Diabetes Management Using Tailored Mobile Coaching: Secondary Analysis of a Randomized Controlled Trial.
    Lee MK; Lee DY; Ahn HY; Park CY
    JMIR Mhealth Uhealth; 2021 Feb; 9(2):e17573. PubMed ID: 33625363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.